Vectormune ND RSS Authorised This medicine is authorised for use in the European Union Newcastle disease and Marek’s disease vaccine (live recombinant) Medicine Veterinary Authorised
Page contentsPage contents Overview Product information Product details Authorisation details Assessment history News on Vectormune ND Topics Application under evaluation CVMP opinion European Commission decision OverviewUp-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website Vectormune ND : EPAR - Summary for the publicReference Number: EMA/464718/2015 English (EN) (81.94 KB - PDF)First published: 12/10/2015 Last updated: 15/02/2024 View Other languages (25) български (BG) (93.36 KB - PDF) First published: 12/10/2015 Last updated: 15/02/2024 View español (ES) (81.97 KB - PDF) First published: 12/10/2015 Last updated: 15/02/2024 View čeština (CS) (93.99 KB - PDF) First published: 12/10/2015 Last updated: 15/02/2024 View dansk (DA) (83.34 KB - PDF) First published: 12/10/2015 Last updated: 15/02/2024 View Deutsch (DE) (82.76 KB - PDF) First published: 12/10/2015 Last updated: 15/02/2024 View eesti keel (ET) (82.18 KB - PDF) First published: 12/10/2015 Last updated: 15/02/2024 View ελληνικά (EL) (93.76 KB - PDF) First published: 12/10/2015 Last updated: 15/02/2024 View français (FR) (82.44 KB - PDF) First published: 12/10/2015 Last updated: 15/02/2024 View hrvatski (HR) (92.27 KB - PDF) First published: 12/10/2015 Last updated: 15/02/2024 View íslenska (IS) (83.29 KB - PDF) First published: 12/10/2015 Last updated: 15/02/2024 View Gaeilge (GA) (83.57 KB - PDF) First published: 12/10/2015 Last updated: 15/02/2024 View italiano (IT) (82.29 KB - PDF) First published: 12/10/2015 Last updated: 15/02/2024 View latviešu valoda (LV) (94.29 KB - PDF) First published: 12/10/2015 Last updated: 15/02/2024 View lietuvių kalba (LT) (94.03 KB - PDF) First published: 12/10/2015 Last updated: 15/02/2024 View magyar (HU) (94.15 KB - PDF) First published: 12/10/2015 Last updated: 15/02/2024 View Malti (MT) (95.95 KB - PDF) First published: 12/10/2015 Last updated: 15/02/2024 View Nederlands (NL) (82.05 KB - PDF) First published: 12/10/2015 Last updated: 15/02/2024 View norsk (NO) (82 KB - PDF) First published: 12/10/2015 Last updated: 15/02/2024 View polski (PL) (95.62 KB - PDF) First published: 12/10/2015 Last updated: 15/02/2024 View português (PT) (83.01 KB - PDF) First published: 12/10/2015 Last updated: 15/02/2024 View română (RO) (94.17 KB - PDF) First published: 12/10/2015 Last updated: 15/02/2024 View slovenčina (SK) (94.08 KB - PDF) First published: 12/10/2015 Last updated: 15/02/2024 View slovenščina (SL) (82.27 KB - PDF) First published: 12/10/2015 Last updated: 15/02/2024 View Suomi (FI) (81.54 KB - PDF) First published: 12/10/2015 Last updated: 15/02/2024 View svenska (SV) (82.05 KB - PDF) First published: 12/10/2015 Last updated: 15/02/2024 View Product information Vectormune ND : EPAR - Product Information English (EN) (81.49 KB - PDF)First published: 12/10/2015 Last updated: 15/02/2024 View Other languages (25) български (BG) (91.78 KB - PDF) First published: 12/10/2015 Last updated: 15/02/2024 View español (ES) (81.51 KB - PDF) First published: 12/10/2015 Last updated: 15/02/2024 View čeština (CS) (92.48 KB - PDF) First published: 12/10/2015 Last updated: 15/02/2024 View dansk (DA) (82.05 KB - PDF) First published: 12/10/2015 Last updated: 15/02/2024 View Deutsch (DE) (81.72 KB - PDF) First published: 12/10/2015 Last updated: 15/02/2024 View eesti keel (ET) (81.22 KB - PDF) First published: 12/10/2015 Last updated: 15/02/2024 View ελληνικά (EL) (91.79 KB - PDF) First published: 12/10/2015 Last updated: 15/02/2024 View français (FR) (81.63 KB - PDF) First published: 12/10/2015 Last updated: 15/02/2024 View hrvatski (HR) (91.56 KB - PDF) First published: 12/10/2015 Last updated: 15/02/2024 View íslenska (IS) (81.52 KB - PDF) First published: 12/10/2015 Last updated: 15/02/2024 View Gaeilge (GA) (81.36 KB - PDF) First published: 12/10/2015 Last updated: 15/02/2024 View italiano (IT) (81.76 KB - PDF) First published: 12/10/2015 Last updated: 15/02/2024 View latviešu valoda (LV) (92.14 KB - PDF) First published: 12/10/2015 Last updated: 15/02/2024 View lietuvių kalba (LT) (92.19 KB - PDF) First published: 12/10/2015 Last updated: 15/02/2024 View magyar (HU) (92.76 KB - PDF) First published: 12/10/2015 Last updated: 15/02/2024 View Malti (MT) (93.86 KB - PDF) First published: 12/10/2015 Last updated: 15/02/2024 View Nederlands (NL) (81.15 KB - PDF) First published: 12/10/2015 Last updated: 15/02/2024 View norsk (NO) (81.52 KB - PDF) First published: 12/10/2015 Last updated: 15/02/2024 View polski (PL) (93.22 KB - PDF) First published: 12/10/2015 Last updated: 15/02/2024 View português (PT) (82.53 KB - PDF) First published: 12/10/2015 Last updated: 15/02/2024 View română (RO) (91.73 KB - PDF) First published: 12/10/2015 Last updated: 15/02/2024 View slovenčina (SK) (81.75 KB - PDF) First published: 12/10/2015 Last updated: 15/02/2024 View slovenščina (SL) (81.76 KB - PDF) First published: 12/10/2015 Last updated: 15/02/2024 View Suomi (FI) (81.11 KB - PDF) First published: 12/10/2015 Last updated: 15/02/2024 View svenska (SV) (81.47 KB - PDF) First published: 12/10/2015 Last updated: 15/02/2024 View Vectormune ND : EPAR - All Authorised presentations English (EN) (81.94 KB - PDF)First published: 12/10/2015 Last updated: 15/02/2024 View Other languages (25) български (BG) (93.36 KB - PDF) First published: 12/10/2015 Last updated: 15/02/2024 View español (ES) (81.97 KB - PDF) First published: 12/10/2015 Last updated: 15/02/2024 View čeština (CS) (93.99 KB - PDF) First published: 12/10/2015 Last updated: 15/02/2024 View dansk (DA) (83.34 KB - PDF) First published: 12/10/2015 Last updated: 15/02/2024 View Deutsch (DE) (82.76 KB - PDF) First published: 12/10/2015 Last updated: 15/02/2024 View eesti keel (ET) (82.18 KB - PDF) First published: 12/10/2015 Last updated: 15/02/2024 View ελληνικά (EL) (93.76 KB - PDF) First published: 12/10/2015 Last updated: 15/02/2024 View français (FR) (82.44 KB - PDF) First published: 12/10/2015 Last updated: 15/02/2024 View hrvatski (HR) (92.27 KB - PDF) First published: 12/10/2015 Last updated: 15/02/2024 View íslenska (IS) (83.29 KB - PDF) First published: 12/10/2015 Last updated: 15/02/2024 View Gaeilge (GA) (83.57 KB - PDF) First published: 12/10/2015 Last updated: 15/02/2024 View italiano (IT) (82.29 KB - PDF) First published: 12/10/2015 Last updated: 15/02/2024 View latviešu valoda (LV) (94.29 KB - PDF) First published: 12/10/2015 Last updated: 15/02/2024 View lietuvių kalba (LT) (94.03 KB - PDF) First published: 12/10/2015 Last updated: 15/02/2024 View magyar (HU) (94.15 KB - PDF) First published: 12/10/2015 Last updated: 15/02/2024 View Malti (MT) (95.95 KB - PDF) First published: 12/10/2015 Last updated: 15/02/2024 View Nederlands (NL) (82.05 KB - PDF) First published: 12/10/2015 Last updated: 15/02/2024 View norsk (NO) (82 KB - PDF) First published: 12/10/2015 Last updated: 15/02/2024 View polski (PL) (95.62 KB - PDF) First published: 12/10/2015 Last updated: 15/02/2024 View português (PT) (83.01 KB - PDF) First published: 12/10/2015 Last updated: 15/02/2024 View română (RO) (94.17 KB - PDF) First published: 12/10/2015 Last updated: 15/02/2024 View slovenčina (SK) (94.08 KB - PDF) First published: 12/10/2015 Last updated: 15/02/2024 View slovenščina (SL) (82.27 KB - PDF) First published: 12/10/2015 Last updated: 15/02/2024 View Suomi (FI) (81.54 KB - PDF) First published: 12/10/2015 Last updated: 15/02/2024 View svenska (SV) (82.05 KB - PDF) First published: 12/10/2015 Last updated: 15/02/2024 View Product details Name of medicine Vectormune ND International non-proprietary name (INN) or common name Newcastle disease and Marek’s disease vaccine (live recombinant) Pharmacotherapeutic groupImmunologicals for avesLive viral vaccinesDomestic fowl Authorisation details EMA product number EMEA/V/C/003829 Assessment history Expand section Collapse section Changes since initial authorisation of medicine Vectormune ND : EPAR - Procedural steps taken and scientific information after authorisation English (EN) (81.94 KB - PDF)First published: 18/02/2020 Last updated: 15/02/2024 View Vectormune ND-V-C-003829-II-0007 : EPAR - Assessment Report - VariationAdopted Reference Number: EMA/72864/2018 English (EN) (81.49 KB - PDF)First published: 10/04/2018 Last updated: 15/02/2024 View CVMP post-authorisation summary of positive opinion for Vectormune ND (II/0007)Adopted Reference Number: EMA/CVMP/739766/2017 English (EN) (68.57 KB - PDF)First published: 19/01/2018 Last updated: 19/01/2018 View Initial marketing authorisation documents Vectormune ND : EPAR - Public assessment reportAdopted Reference Number: EMA/469665/2015 English (EN) (81.49 KB - PDF)First published: 12/10/2015 Last updated: 15/02/2024 View CVMP summary of positive opinion for Vectormune NDAdopted Reference Number: EMA/CVMP/354791/2015 English (EN) (70.66 KB - PDF)First published: 10/07/2015 Last updated: 10/07/2015 View News on Vectormune ND Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 8-9 April 202511/04/2025 Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 16-18 July 202419/07/2024 Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 7-9 November 202310/11/2023 Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 10-12 May 202213/05/2022 Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 13-15 July 202116/07/2021 Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 16-17 February 202119/02/2021 Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 18-20 May 202025/05/2020 Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 5-7 November 201908/11/2019 Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 10-12 September 201913/09/2019 Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 17-19 April 201820/04/2018 Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 13-15 March 201816/03/2018 Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 16-18 January 201819/01/2018 Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 7–9 November 201710/11/2017 Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 11-13 July 201714/07/2017 Committee for Medicinal Products for Veterinary Use (CVMP) Meeting of 17-19 January 201720/01/2017 Committee for Medicinal Products for Veterinary Use (CVMP) Meeting of 12-14 July 201615/07/2016 Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 4-6 November 201509/11/2015 Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 7-9 July 201510/07/2015 Topics Medicines Vaccines This page was last updated on 15/02/2024 Share this page